By Cort Johnson in Health Rising.
A study seeking to uncover a diagnostic biomarker for chronic fatigue syndrome (ME/CFS) that you can participate in from your home? That was unexpected.
I had never heard of Dxterity or the CHROME (CHRonic fatigue syndrOME) study until a couple of days ago. The company – a biological diagnostic company based in Los Angeles – has four other studies underway. Besides their catchy titles, the studies had two things in common: they were all focused on more cheaply and effectively monitoring autoimmune diseases.
- LIFT (Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization) study for Lupus
- EMPOWER study (Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response) for multiple sclerosis
- BRAVO (Baseline Rheumatoid Arthritis Verification Outcomes)
To read the rest of this story, click on the link below: